malaria_record: 41

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

This data as json

record_id country_id valid_from valid_to is_current source_id fetch_run_id payload_sha256 content_hash area_of_risk_html relative_risk_html chloroquine_resist_html species_html recommended_prophylaxis_html cdc_updated_date has_transmission is_endemic whole_country_endemic country_has_any_prophylaxis_area screening_class prophylaxis_drugs_json species_json chloroquine_resistant area_summary created_at
41 41 2026-06-03   1 1 1 8eab5796788447f748d742bc3ea9c689b7dd02e0761828d2fa9fd151f54f3515 2d5ed3d39c88bdd8d7a42494f3c08aca894d2cdf5fa872d04e66e5681a63e2c5
  • All areas (including game parks) <2,500 m (<8,200 ft) elevation; rare cases in the highly urbanized central part of the city of Nairobi (the capital)

the counties of Garissa (last case reported 6-9 months ago), Kisumu (last case reported 9-12 months ago), Kwale (last case reported 9-12 months ago), Migori (last case reported 3-6 months ago), Mombasa (last case reported 9-12 months ago), Nairobi (last case reported 6-9 months ago), Narok (last case reported 6-9 months ago), and Turkana (last case reported 6-9 months ago)
  • Chloroquine
  • P. falciparum (primarily)
  • P. malariae, P. ovale, and P. vivax (less commonly)
  • Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
  • Highly urbanized central part of the city of Nairobi: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
Updated April 23, 2025
 2025-04-23 1 1 0 1 partial ["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"] ["P. falciparum", "P. malariae", "P. ovale", "P. vivax"] 1 All areas (including game parks) <2,500 m (<8,200 ft) elevation; rare cases in the highly urbanized central part of the city of Nairobi (the capital) 2026-06-03T22:10:28Z

Links from other tables